BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 19085758)

  • 1. Laboratory diagnostics in thrombosis and hemostasis: the past, the present, and the future.
    Favaloro EJ; Lippi G; Franchini M
    Semin Thromb Hemost; 2008 Oct; 34(7):579-83. PubMed ID: 19085758
    [No Abstract]   [Full Text] [Related]  

  • 2. Laboratory diagnostics and therapy in thrombosis and hemostasis: from bedside to bench to bedside.
    Lippi G; Favaloro EJ; Franchini M
    Semin Thromb Hemost; 2009 Feb; 35(1):3-8. PubMed ID: 19308888
    [No Abstract]   [Full Text] [Related]  

  • 3. Approaches to investigating common bleeding disorders: an evaluation of North American coagulation laboratory practices.
    Hayward CP; Moffat KA; Plumhoff E; Van Cott EM
    Am J Hematol; 2012 May; 87 Suppl 1():S45-50. PubMed ID: 22367923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lengthening of the kaolin or activated cephalin time (KCT, ACT), Quick's time, bleeding time. Diagnostic direction].
    Drouet L
    Rev Prat; 1999 Oct; 49(16):1809-18. PubMed ID: 10578614
    [No Abstract]   [Full Text] [Related]  

  • 5. Is the activated partial thromboplastin time suitable to screen for von Willebrand factor deficiencies?
    Lippi G; Franchini M; Poli G; Salvagno GL; Montagnana M; Guidi GC
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):361-4. PubMed ID: 17473578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of abnormal preoperative hemostatic tests.
    Bowie EJ; Owen CA
    Prog Hemost Thromb; 1980; 5():179-209. PubMed ID: 6775346
    [No Abstract]   [Full Text] [Related]  

  • 7. [Haemostatic testing prior to elective surgery? Yes!].
    Albert FW; Eichler H; Haubelt H; Loreth R; Matzdorff A; Peetz D; Pindur G; Schinzel H; Seyfert U; Hellstern P;
    Hamostaseologie; 2009 Jan; 29(1):58-63. PubMed ID: 19151848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Problems of haemostasis and coagulation. Diagnostic orientation].
    Bezeaud A; Guillin MC; Fischer AM
    Rev Prat; 2007 Feb; 57(3):327-35. PubMed ID: 17578036
    [No Abstract]   [Full Text] [Related]  

  • 9. Essential thrombocythaemia in a teenage girl resulting in acquired von Willebrand syndrome with joint haemorrhage and menorrhagia.
    Rolf N; Suttorp M; Budde U; Siegert G; Knoefler R
    Thromb Haemost; 2010 Jun; 103(6):1272-4. PubMed ID: 20352170
    [No Abstract]   [Full Text] [Related]  

  • 10. External quality assessment schemes in coagulation in Germany: between regulatory bodies and patient outcome.
    Spannagl M; Dick A; Reinauer H
    Semin Thromb Hemost; 2007 Apr; 33(3):259-64. PubMed ID: 17427060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory assessment of familial, nonthrombocytopenic mucocutaneous bleeding: a definitive diagnosis is often not possible.
    Pereira J; Quiroga T; Mezzano D
    Semin Thromb Hemost; 2008 Oct; 34(7):654-62. PubMed ID: 19085766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of the second-derivative curve of activated partial thromboplastin time on the ACL-TOP coagulation analyzer for detecting factor deficiencies.
    Tokunaga N; Inoue C; Sakata T; Kagawa K; Abe M; Takamatsu N; Nakao T; Doi T
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):474-6. PubMed ID: 26523912
    [No Abstract]   [Full Text] [Related]  

  • 14. Standardization and clinical utility of thrombin-generation assays.
    Berntorp E; Salvagno GL
    Semin Thromb Hemost; 2008 Oct; 34(7):670-82. PubMed ID: 19085768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common bleeding problems.
    Moake JL; Funicella T
    Clin Symp; 1983; 35(3):1-32. PubMed ID: 6336273
    [No Abstract]   [Full Text] [Related]  

  • 16. Elderly female with a personal and family history of a bleeding disorder.
    Desai DS; Lyon E; Rodgers GM; Jama MA; Wallentine SL; Smock KJ
    Clin Chem; 2015 Jul; 61(7):909-12. PubMed ID: 26116638
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory management of the bleeding patient.
    Taylor LJ
    Clin Lab Sci; 2003; 16(2):111-4. PubMed ID: 12757191
    [No Abstract]   [Full Text] [Related]  

  • 18. Standardization, regulation, quality assurance and emerging technologies in hemostasis: issues, controversies, benefits, and limitations.
    Favaloro EJ
    Semin Thromb Hemost; 2007 Apr; 33(3):290-7. PubMed ID: 17427064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biological diagnosis of Willebrand disease].
    Siguret V; Ribba AS; Meyer D
    Ann Biol Clin (Paris); 1997; 55(6):601-6. PubMed ID: 9499922
    [No Abstract]   [Full Text] [Related]  

  • 20. Tests of coagulation. Use and interpretation.
    Lerner RG; Goldstein R
    Med Clin North Am; 1973 Nov; 57(6):1609-16. PubMed ID: 4270514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.